Back

Brain Structure and Substance Use: Disentangling Risk, Exposure, and Drug-Specific Effects

Fernandez, D.; Baranger, D. A.

2026-03-23 psychiatry and clinical psychology
10.64898/2026.03.20.26348897 medRxiv
Show abstract

ImportancePolysubstance use is common, but substance use associations with neuroimaging measures have largely been investigated within individual drug types. Whether effects are substance-specific or -general, and how predispositional risk and exposure contribute, remains unclear. ObjectiveIdentify shared and unique associations between substance use and brain structure, and characterize the contributions of predispositional risk and environmental exposure, in a large sample of young adults in the US. DesignThis cross-sectional family-based study used data from the Human Connectome Project (2017 release, collected from 2012-2015). SettingData were collected at Washington University in St. Louis, MO, USA. ParticipantsTwins, non-twin siblings, and singletons with magnetic resonance imaging (MRI) and substance use self-report were included in the analysis. Data were analyzed in 2025. ExposureHistory of substance use was assessed using the Semi-Structured Assessment for the Genetics of Alcoholism. Variables included lifetime use, heavy or past-year hazardous use, and age of use onset for alcohol, marijuana, tobacco, and illicit drugs. Additionally, alcohol and marijuana dependence were assessed. Main Outcomes and MeasuresLinear mixed-effect models examined associations between substance use and brain structure, with an initial focus on past-year hazardous alcohol use, as 95% of the sample endorsed lifetime alcohol use. Analyses then tested associations with other substance use variables, and whether effects were shared or substance-specific. Between-family, within-family, and genetic variance component analyses tested risk and exposure effects. Results1,113 participants (N = 445 families; ages 22 - 37; M=28.8, SD=3.7) had no missing data for the primary analyses. Hazardous alcohol use was negatively associated with global brain thickness ({beta} = -0.12, p < 0.001), which explained all other regional and global associations. Of the drugs with a shared-effect on global brain thickness, only lifetime marijuana use explained unique variance over alcohol ({beta} = -0.08, p = 0.013). Within-family analyses found evidence for unique putative exposure effects of both alcohol ({beta} = -0.11, p < 0.001) and marijuana use ({beta} = -0.07, p = 0.002) on global thickness. Marijuana use further showed a predispositional effect, both in between-family comparisons ({beta} = -0.11, p = 0.007) and genetic variance component analyses ({rho}G = -0.2, p = 0.004), which were not explained by alcohol use. Conclusions and RelevanceBrain structural associations with substance use reflect substance-general and -specific effects, as well as a combination of predispositional and exposure effects. Findings suggest that the negative consequences of polysubstance use may reflect the additive effects of multiple unique exposures.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
JAMA Network Open
127 papers in training set
Top 0.2%
10.0%
2
Alcohol, Clinical and Experimental Research
12 papers in training set
Top 0.1%
8.3%
3
Neuropsychopharmacology
134 papers in training set
Top 0.4%
7.1%
4
Alcoholism: Clinical and Experimental Research
13 papers in training set
Top 0.1%
6.7%
5
Drug and Alcohol Dependence
37 papers in training set
Top 0.2%
6.2%
6
Addiction Biology
47 papers in training set
Top 0.3%
4.3%
7
Translational Psychiatry
219 papers in training set
Top 2%
3.9%
8
NeuroImage: Clinical
132 papers in training set
Top 1%
3.6%
50% of probability mass above
9
Psychological Medicine
74 papers in training set
Top 0.5%
3.6%
10
Biological Psychiatry Global Open Science
54 papers in training set
Top 0.2%
3.5%
11
The British Journal of Psychiatry
21 papers in training set
Top 0.4%
2.1%
12
Psychopharmacology
59 papers in training set
Top 0.3%
2.1%
13
Addiction
25 papers in training set
Top 0.2%
1.9%
14
Journal of Psychopharmacology
14 papers in training set
Top 0.2%
1.9%
15
European Neuropsychopharmacology
15 papers in training set
Top 0.2%
1.8%
16
American Journal of Psychiatry
20 papers in training set
Top 0.2%
1.7%
17
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging
62 papers in training set
Top 0.9%
1.7%
18
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.4%
1.6%
19
Cerebral Cortex
357 papers in training set
Top 0.9%
1.6%
20
PLOS ONE
4510 papers in training set
Top 57%
1.5%
21
JAMA Psychiatry
13 papers in training set
Top 0.3%
1.3%
22
Molecular Psychiatry
242 papers in training set
Top 2%
1.3%
23
BMC Medicine
163 papers in training set
Top 5%
0.9%
24
European Psychiatry
10 papers in training set
Top 0.6%
0.9%
25
PLOS Medicine
98 papers in training set
Top 4%
0.9%
26
Developmental Cognitive Neuroscience
81 papers in training set
Top 0.5%
0.9%
27
Pharmacology Biochemistry and Behavior
17 papers in training set
Top 0.3%
0.9%
28
Human Brain Mapping
295 papers in training set
Top 4%
0.7%
29
Nature Communications
4913 papers in training set
Top 63%
0.7%
30
Psychiatry and Clinical Neurosciences
11 papers in training set
Top 0.4%
0.7%